Veloce BioPharma Patents – Insights & Stats (Updated 2023)

Veloce BioPharma has a total of 110 patents globally, out of which 33 have been granted. Of these 110 patents, more than 21% patents are active. United States of America is where Veloce BioPharma has filed the maximum number of patents, followed by Japan and Korea (South). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Veloce BioPharma.

Veloce BioPharma was founded in the year 2015. The Company is a Florida based biotechnology company focused on the development of products for viral, fungal and bacterial infections.

Do read about some of the most popular patents of Veloce BioPharma which have been covered by us in this article and also you can find Veloce BioPharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Veloce BioPharma patent portfolio.

How many patents does Veloce BioPharma have?

Veloce BioPharma has a total of 110 patents globally. These patents belong to 10 unique patent families. Out of 110 patents, 24 patents are active.

How Many Patents did Veloce BioPharma File Every Year?

Veloce BioPharma Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantVeloce BioPharma Applications FiledVeloce BioPharma Patents Granted
20232
20211
202084
2019412
2018147
2017406
2016221
20141
20131
201220

How many Veloce BioPharma patents are Alive/Dead?

Veloce BioPharma Patent Portfolio

How Many Patents did Veloce BioPharma File in Different Countries?

Veloce BioPharma Worldwide Patent Filing

Countries in which Veloce BioPharma Filed Patents

CountryPatents
United States of America18
Japan15
Korea (South)11
Europe8
China6
Hong Kong (S.A.R.)6
Mexico4
Canada4
Philippines3
Austria3
Germany3
Spain3
Indonesia3
Singapore2
Brazil2
Malaysia2
Netherlands2
Thailand1
Viet Nam1
Australia1
Denmark1
India1

Where are Research Centres of Veloce BioPharma Patents Located?

R&D Centers of Veloce BioPharma

10 Best Veloce BioPharma Patents

WO2016118424A1 is the most popular patent in the Veloce BioPharma portfolio. It has received 12 citations so far from companies like Tai Ming Pharmaceuticals and Vietnam Shang Tai Minh Pharmaceutical.

Below is the list of 10 most cited patents of Veloce BioPharma:

Publication NumberCitation Count
WO2016118424A112
US20170071979A13
US20190160003A12
WO2019135779A12
WO2017193060A12
JP2019038795A2
JP2018070583A2
JP2018506577A2
US9770466B21
US10398656B11

What Percentage of Veloce BioPharma US Patent Applications were Granted?

Veloce BioPharma (Excluding its subsidiaries) has filed 14 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 42.86%.

Below are the key stats of Veloce BioPharma patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Veloce BioPharma?

Law FirmTotal ApplicationsSuccess Rate
Studebaker & Brackett Pc1442.86%

What are Veloce BioPharma key innovation segments?

What Technologies are Covered by Veloce BioPharma?

The chart below distributes patents filed by Veloce BioPharma in different countries on the basis of the technology protected in patents. It also represents the markets where Veloce BioPharma thinks it’s important to protect particular technology inventions.

R&D Focus: How has Veloce BioPharma search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Veloce BioPharma?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.